Cinctive Capital Management LP

Source: SEC Form 13F · as of Mar 2026

Cinctive Capital Management LP holds 68 biotech & pharma companies tracked by BioSniper, totaling $243.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

68

Total value held

$243.0M

CompanySharesValue
INSMINSMED Inc73,063$11.9M
BBIOBridgeBio Pharma, Inc.145,728$10.8M
DAWNDay One Biopharmaceuticals, Inc.450,000$9.6M
LLYELI LILLY & Co10,008$9.2M
ACLXArcellx, Inc.80,000$9.2M
RVMDREVOLUTION MEDICINES, INC.93,857$9.1M
SRRKScholar Rock Holding Corp172,535$8.5M
JNJJOHNSON & JOHNSON34,668$8.5M
MDGLMADRIGAL PHARMACEUTICALS, INC.15,326$8.0M
DNTHDianthus Therapeutics, Inc. /DE/94,408$7.9M
ROIVRoivant Sciences Ltd.274,521$7.6M
REGNREGENERON PHARMACEUTICALS, INC.9,278$7.2M
UNHUnitedHealth Group Incorporated Common Stock (DE)25,194$6.8M
BMYBRISTOL MYERS SQUIBB CO110,079$6.7M
JAZZJazz Pharmaceuticals plc34,686$6.6M
AZNASTRAZENECA PLC30,971$6.1M
CAHCardinal Health Inc.27,174$5.7M
ARGXARGENX SE7,687$5.6M
TARSTarsus Pharmaceuticals, Inc.68,769$4.8M
TNGXTango Therapeutics, Inc.222,111$4.6M
ELVNEnliven Therapeutics, Inc.113,342$4.4M
PCVXVaxcyte, Inc.74,547$4.3M
VERAVera Therapeutics, Inc.106,084$4.3M
FOLDAMICUS THERAPEUTICS, INC.275,000$4.0M
UTHRUNITED THERAPEUTICS Corp6,515$3.9M
MRNAModerna, Inc.76,043$3.9M
TEVATeva Pharmaceutical Industries Limited122,133$3.7M
MIRMMirum Pharmaceuticals, Inc.38,518$3.6M
BIIBBIOGEN INC.19,349$3.5M
ARWRARROWHEAD PHARMACEUTICALS, INC.49,068$3.1M
CORCencora Inc.9,635$3.0M
TYRATyra Biosciences, Inc.78,018$3.0M
ERASErasca, Inc.171,920$2.8M
SNDXSyndax Pharmaceuticals Inc117,319$2.7M
COGTCogent Biosciences, Inc.68,761$2.6M
CYTKCYTOKINETICS INC35,062$2.3M
VRTXVERTEX PHARMACEUTICALS INC / MA5,049$2.3M
FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)99,004$2.2M
ABVXAbivax SA20,055$2.2M
RGENREPLIGEN CORP18,334$2.2M
MRKMerck & Co., Inc.16,707$2.0M
QUREuniQure N.V.107,345$1.8M
CGONCG Oncology, Inc.25,017$1.7M
ANNXAnnexon, Inc.268,640$1.5M
SYRESpyre Therapeutics, Inc.27,430$1.4M
TERNTerns Pharmaceuticals, Inc.26,184$1.4M
CGEMCullinan Therapeutics, Inc.94,444$1.3M
CLDXCelldex Therapeutics, Inc.41,233$1.3M
LEGNLegend Biotech Corp69,586$1.3M
SNYSanofi22,936$1.1M
CNTACentessa Pharmaceuticals plc25,350$1.0M
LQDALiquidia Corp25,349$957K
ACHCAcadia Healthcare Company Inc.40,000$936K
PFEPFIZER INC31,828$894K
ADPTAdaptive Biotechnologies Corp53,884$748K
KRYSKrystal Biotech, Inc.2,874$742K
NRIXNurix Therapeutics, Inc.45,171$700K
OCULOCULAR THERAPEUTIX, INC68,349$579K
GPCRStructure Therapeutics Inc.8,714$420K
TVTXTravere Therapeutics, Inc.13,966$415K
ELANElanco Animal Health Inc16,629$398K
IDYAIDEAYA Biosciences, Inc.10,869$362K
BHVNBiohaven Ltd.37,017$313K
VTRSViatris Inc20,000$270K
CMPXCompass Therapeutics, Inc.48,740$258K
DFTXDefinium Therapeutics Inc.12,551$237K
DVADaVita Inc.1,514$233K
VRDNViridian Therapeutics, Inc.\DE11,480$225K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.